Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients. 1989

S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
Osaka City University Medical School, Japan.

The relationship between endotoxin, which was detected in the dialysate, and incidence of its antibody formation in long-term hemodialysis patients was studied. Bacteria in the dialysate were first obtained, identified, and cultured, and then endotoxin was obtained from the bacteria by extraction with phenol. Using the endotoxin obtained and Escherichia coli J-5 as the antigen, the endotoxin antibody was measured in the serum of long-term hemodialysis patients by enzyme-linked immunosorbant assay (ELISA). It was found that the percentage of endotoxin antibody-positive patients was significantly higher in hemodialysis patients when compared with healthy controls. It was also significantly higher in hemodialysis patients using synthetic polymer membrane dialyzers compared with those using cuprophan membrane dialyzers. These results suggest that endotoxin antibody detected in hemodialysis patients was derived from the dialysate, and that the dialysate must be kept bacteria free, especially in patients using high-flux, highly permeable membrane dialyzers.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D015312 Hemodialysis Solutions Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (Na+, K+, Ca2+), and addition of carbohydrates (glucose). Solutions, Hemodialysis,Dialysis Solutions, Hemodialysis,Hemodialysates,Hemodialyzates,Hemodialysis Dialysis Solutions,Solutions, Hemodialysis Dialysis
D015314 Dialysis Solutions Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. Dialysate,Dialysis Solution,Dialyzate,Dialysates,Dialyzates,Solution, Dialysis,Solutions, Dialysis

Related Publications

S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1984, Uremia investigation,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1984, American journal of nephrology,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1988, Nephron,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1976, Transactions - American Society for Artificial Internal Organs,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
July 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 2008, Renal failure,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1980, Transactions - American Society for Artificial Internal Organs,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
July 1975, Nihon Jinzo Gakkai shi,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
January 1976, Minerva nefrologica,
S Yamagami, and T Adachi, and T Sugimura, and T Kishimoto, and M Maekawa, and M Niwa, and S Shaldon
September 2023, Kidney international reports,
Copied contents to your clipboard!